The Technology Co.,Ltd.

Equities

A043090

KR7043090000

Industrial Machinery & Equipment

End-of-day quote Korea S.E. Other stock markets 23:00:00 13/05/2024 BST			5-day change	1st Jan Change
422 ^KRW	0.00%		-2.09%	-34.06%

03-22	PangSky Corp. announced that it has received KRW 1 billion in funding from Exergy21 Co., Ltd.	CI
03-21	PangSky Corp. announced that it expects to receive KRW 1 billion in funding from Exergy21 Co., Ltd.	CI

Hanchang Biotech Co., Ltd. acquired 5.61% stake in Hanju Chemical Company Ltd for KRW 2.7 billion.

December 26, 2021

Hanchang Biotech Co., Ltd. (KOSDAQ:A043090) acquired 5.61% stake in Hanju Chemical Company Ltd for KRW 2.7 billion on December 27, 2021.

Hanchang Biotech Co., Ltd. (KOSDAQ:A043090) completed the acquisition of 5.61% stake in Hanju Chemical Company Ltd on December 27, 2021.

Latest news about The Technology Co.,Ltd.

PangSky Corp. announced that it has received KRW 1 billion in funding from Exergy21 Co., Ltd.	03-21	CI
PangSky Corp. announced that it expects to receive KRW 1 billion in funding from Exergy21 Co., Ltd.	03-20	CI
Exergy21 Co., Ltd. announced that it expects to receive KRW 24.999999475 billion in funding	17/08/23	CI
Kattus Co., Ltd. announced that it has received KRW 5.999 billion in funding from Exergy21 Co., Ltd.	02/05/23	CI
Kattus Co., Ltd. announced that it expects to receive KRW 5.999 billion in funding from Exergy21 Co., Ltd.	25/04/23	CI
Exergy21 Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	21/03/23	CI
Exergy21 Co., Ltd. announced that it expects to receive KRW 25 billion in funding	15/03/23	CI
Hanchang Biotech Co., Ltd. announced that it has received KRW 15 billion in funding from Exergy21.Inc	16/10/22	CI
HanChang Biotech to Raise $9.2 Million Through Stock Offering	05/08/22	MT
Hanchang Corporation entered into an agreement to acquire 73.98% for KRW 25 billion.	04/08/22	CI
Exergy21 Co., Ltd. announced that it expects to receive KRW 79.99999938 billion in funding from Jeonheung CNC Co., Ltd.	03/08/22	CI
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 12.5 billion in funding from Jeonheung CNC Co., Ltd.	03/08/22	CI
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 15 billion in funding from Exergy21.Inc	03/08/22	CI
An undisclosed buyer agreed to acquire 8.6% stake in Hanchang Biotech Co., Ltd. from Hanchang Corporation for KRW 6.8 billion.	03/08/22	CI
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 27.49999938 billion in funding	03/08/22	CI
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 11.99999925 billion in funding from Jeonheung CNC Co., Ltd.	03/08/22	CI
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 12.49999938 billion in funding from Jeonheung CNC Co., Ltd.	03/08/22	CI
Hanchang Biotech Co., Ltd. acquired 5.61% stake in Hanju Chemical Company Ltd for KRW 2.7 billion.	26/12/21	CI
Hanju Chemical & Holdings Co., Ltd. announced that it has received KRW 12.49999978 billion in funding from Hanchang Corporation, Jaanh Holdings Co., Ltd., CHOROKBAEM COMPANY Co., Ltd.	28/10/21	CI
Hanju Chemical & Holdings Co., Ltd. announced that it has received KRW 8 billion in funding from Jiyuon Co., Ltd.	20/10/21	CI
Hanju Chemical & Holdings Co., Ltd. announced that it expects to receive KRW 8 billion in funding from Jiyuon Co., Ltd.	18/10/21	CI
Cube&Company Co., Ltd. announced that it expects to receive KRW 17.49999934 billion in funding from Jaanh Cosmetics, Inc.	15/06/21	CI
Cube&Company Co., Ltd. announced that it expects to receive KRW 12.49999978 billion in funding from CHOROKBAEM COMPANY Co., Ltd.	28/03/21	CI
PharmswellBio Co., Ltd. announced that it has received KRW 4.999997086 billion in funding from Cube Partners, C.S. Global Co., Ltd.	23/09/19	CI
PharmswellBio Co., Ltd.(KOSDAQ:A043090) dropped from S&P Global BMI Index	23/09/19	CI

Chart The Technology Co.,Ltd.

Duration

Period

More charts

Company Profile

The Technology Co Ltd, formerly Exergy21 Co Ltd, is a Korea-based company mainly engaged in the distribution business. The Company manly operates its business through four segments. The Distribution Business segment engages in the food processors, luxury goods, healthy food, kitchen appliances and home shopping goods distribution business. The PM business segment provides consulting services for real estate development, licensing, and contractor selection. The Pharmaceutical segment engages in ethanol and disinfectant manufacture business. The Other segment provides business support services. The Company also engages in information technology (IT) services, artificial intelligence (AI) and drone based security solutions, as well as heat pump system provision business.

Sector

Industrial Machinery & Equipment

More about the company

Income Statement Evolution

More financial data

Sector Industrial Machinery & Equipment Wholesale

	1st Jan change	Capi.
THE TECHNOLOGY CO.,LTD.	-34.06%	22.11M
W.W. GRAINGER, INC.	+15.62%	47.02B
FASTENAL COMPANY	+3.41%	38.35B
APPLIED INDUSTRIAL TECHNOLOGIES, INC.	+15.69%	7.71B
DIPLOMA PLC	+15.91%	7B
MSC INDUSTRIAL DIRECT CO., INC.	-7.86%	5.25B
DISTRIBUTION SOLUTIONS GROUP, INC.	+12.93%	1.67B
DNOW INC.	+23.14%	1.49B
BUFAB AB	-4.55%	1.3B
MRC GLOBAL INC.	+26.25%	1.18B

Industrial Machinery & Equipment Wholesale